Netherlands· NL-5028f11b79b7
Atrovent 20 microgram/dosis, aërosol, oplossing
A ipratropium bromide product containing ipratropiumbromide 1-water, registered in Netherlands by Boehringer Ingelheim B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ipratropium bromide is registered in 13 of 19 countries.
Countries holding a registration under ATC R03BB01 (ipratropium bromide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Ipratropium bromide · ATC R03BB01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- IPRATROPIUMBROMIDE 1-WATER
- Manufacturer
- Boehringer Ingelheim B.V.
- Country
- Netherlands (NL)
- ATC code
- R03BB01
- ATC class
- Ipratropium bromide
- Defined daily dose
- 0.12 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id26834
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
114 interactions on record for ipratropium bromide.
Graded by severity as the source publishes them — 114 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ipratropium bromide · interactions on record
114 records
- 114 moderate
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ipratropium bromide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAtrovent 20micrograms/dose AutohalerBoehringer Ingelheim Ltd
- United StatesAtroventBoehringer Ingelheim Pharmaceuticals, Inc.
- FinlandAtroventParanova Oy
- SwedenAtrovent 0,25 mg/ml Lösning för nebulisatorBoehringer Ingelheim International GmbH
- BelgiumAtronase 0.3 mg/mlSanofi Belgium
- FranceATROVENT 20 microgrammes/dose, solution pour inhalation en flacon pressuriséBOEHRINGER INGELHEIM FRANCE
- GermanyAtroventBoehringer Ingelheim Pharma Gmbh & Co. Kg
- CanadaAA-IPRAVENTAA PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Atrovent - Dosieraerosol, Ipratropiumbromid Infectopharm
- Belgium · Atrovent, Atrovent Hfa
- Cyprus · Atrovent
- Czechia · Atrovent, Atrovent N
- Germany · Atrovent, Atrovent Ls
- Denmark · Atrovent, Ipratropiumbromid Teva
- Estonia · Atrovent N
- Spain · Atroaldo, Atrovent
- Finland · Atrovent, Atrovent Eco
- France · Atrovent, Atrovent Adultes
- United Kingdom (Northern Ireland) · Atrovent Inhaler Cfc-Free, Atrovent Udvs
- Greece · Atrovent, Broncovent
- Croatia · Atrovent, Atrovent N
- Hungary · Atrovent N
- Ireland · Atrovent 250 Udvs, Atrovent 500 Udvs
- Iceland · Atrovent, Lomuspray
- Italy · Atem, Nasipral
- Lithuania · Atrovent N
- Luxembourg · Atrovent, Atrovent Hfa
- Malta · Atroaldo, Atrovent Inhaler Cfc-Free
- Norway · Atrovent, Ipraxa
- Poland · Atrodil, Atrovent
- Portugal · Atrovent, Atrovent Pa
- Romania · Ipravent Inhaler
- Sweden · Atrovent, Ipravent
- Slovakia · Atrovent N
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/02f83f2a-3cd7-43fb-896e-58c267dcd92a GET /v1/drugs/02f83f2a-3cd7-43fb-896e-58c267dcd92a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aërosol, oplossing",
"route": "Inhalatie",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h26834_smpc.pdf",
"strength": null,
"atc_label": "Ipratropium Bromide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg26834",
"excipients": [
"CITROENZUUR 0-WATER (E 330)",
"ETHANOL",
"NORFLURAAN",
"WATER, GEZUIVERD"
],
"substances": [
"IPRATROPIUMBROMIDE 1-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h26834.pdf",
"authorised_at": "2001/11/14",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "26834",
"additional_monitoring": "N"
}See everything about ipratropium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.